Archive : 上海夜网A

Maple Leafs’ Jake Muzzin released from hospital, out for rest of qualifying round

first_imgMuzzin went down on one knee along the boards as he played the puck and, as he tried to get up, appeared to hit a rut with the front of his skate and fell awkwardly into the leg of Columbus’ Oliver Bjorkstrand.The veteran’s head and neck seemed to be impacted in the collision, resulting in the stretcher coming out; he was seen opening and closing his hands and moving his legs after the incident and head coach Sheldon Keefe said he was “responsive” at the hospital.#LeafsForever Jake Muzzin hurt here pic.twitter.com/o8isPdgCxp— Here’s Your Replay ⬇️ (@TheReplayGuy) August 4, 2020″Seeing a guy like Jake, that everyone cares about, he’s very well-loved in the locker room,” said netminder Frederik Andersen. “Being as tough as [he is], it’s really hard to see him being told to lay down and not move. … We’re just thinking about him and making sure that all the right steps are being taken and hopefully recover soon.””He does a big part for this team: penalty kill, even strength against the best players, against the other team,” added Mitch Marner, who was on the ice when Muzzin got hurt. “He really does mean a lot to us so, you know, kind of being beside him there when he did go down, stay down, obviously, it’s a little worrisome.”Without fans in attendance, it was incredibly quiet inside the arena as both teams looked on with concern. As Muzzin was stretchered off, both teams tapped their sticks.”Seeing one of your teammates go down, especially a guy like Muzz, you know the type of warrior he is. I think what he brings to our team is unmeasurable,” said captain John Tavares. “Obviously, very tough. All signs were very positive being around him and nice to close it out for him but certainly tough to see, especially just how much we love that guy.” It was a scary scene at Scotiabank Arena on Tuesday afternoon as Maple Leafs defenseman Jake Muzzin was stretchered off late in the third period. Thankfully, Muzzin was released from the hospital Wednesday and is back at the team’s hotel. He will be out for the remainder of the team’s series against the Blue Jackets because of the injury.With Toronto on the penalty kill, the Blue Jackets’ Pierre-Luc Dubois cross-checked Muzzin from behind when he was about to go around the back of his own net. The injury came with just under two minutes left in the Maple Leafs’ 3-0 win over Columbus, evening the qualifying round series at 1. Game 3 is Thursday at 8 p.m. ET. In practice on Wednesday, Travis Dermott shifted up to play with Muzzin’s defensive partner Justin Holl. Martin Marincin slotted in with Tyson Barrie on the team’s third pairing.Because he left the bubble to go to the hospital, Muzzin is quarantining and, per Leafs PR, will “remain in quarantine within the hotel and look to rejoin his teammates upon recovery.”last_img read more

NIH in uproar over report slamming Clinical Center leadership shakeup

first_imgA decision to overhaul the leadership of the National Institutes of Health (NIH) Clinical Center after an outside review group found serious patient safety problems has sparked an uproar at the NIH campus in Bethesda, Maryland. In a recent letter, department chiefs at the center wrote that the review, triggered by problems with a drug production facility, unfairly concluded that patient safety has been compromised across the research hospital. They say the working group’s report has demoralized staff, worried patients, and “demonized” the center’s leadership.Patient advocates and clinical research leaders across NIH have also written letters taking issue with the review. NIH Director Francis Collins yesterday responded to one of the letters, from Clinical Center department heads. In a statement, Collins said he is “taking the comments … very seriously. They are highly dedicated senior leaders, and I have great respect for all of them.” At the same time, he “stand[s] by” the outside working group’s process and expertise and agrees that the center needs “more central authority and accountability.” Collins was expected to meet with clinical leaders today to discuss their concerns. Click to view the privacy policy. Required fields are indicated by an asterisk (*) Email The Clinical Center’s troubles began about a year ago, when fungal contamination was found in two vials of a drug from a sterile production unit in the center’s pharmaceutical development section. A review found other problems at the facility, such as insects in light fixtures. Although no patients were harmed, in December 2015 Collins asked a so-called Red Team—a working group of his Advisory Committee to the Director—to review the entire Clinical Center. The team’s April report found “substantial operations issues” with patient safety, regulatory compliance, and leadership. It described a culture in which patient safety “became subservient to research demands.” Country * Afghanistan Aland Islands Albania Algeria Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia, Plurinational State of Bonaire, Sint Eustatius and Saba Bosnia and Herzegovina Botswana Bouvet Island Brazil British Indian Ocean Territory Brunei Darussalam Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos (Keeling) Islands Colombia Comoros Congo Congo, the Democratic Republic of the Cook Islands Costa Rica Cote d’Ivoire Croatia Cuba Curaçao Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands (Malvinas) Faroe Islands Fiji Finland France French Guiana French Polynesia French Southern Territories Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Heard Island and McDonald Islands Holy See (Vatican City State) Honduras Hungary Iceland India Indonesia Iran, Islamic Republic of Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Korea, Democratic People’s Republic of Korea, Republic of Kuwait Kyrgyzstan Lao People’s Democratic Republic Latvia Lebanon Lesotho Liberia Libyan Arab Jamahiriya Liechtenstein Lithuania Luxembourg Macao Macedonia, the former Yugoslav Republic of Madagascar Malawi Malaysia Maldives Mali Malta Martinique Mauritania Mauritius Mayotte Mexico Moldova, Republic of Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island Norway Oman Pakistan Palestine Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Qatar Reunion Romania Russian Federation Rwanda Saint Barthélemy Saint Helena, Ascension and Tristan da Cunha Saint Kitts and Nevis Saint Lucia Saint Martin (French part) Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Sint Maarten (Dutch part) Slovakia Slovenia Solomon Islands Somalia South Africa South Georgia and the South Sandwich Islands South Sudan Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Swaziland Sweden Switzerland Syrian Arab Republic Taiwan Tajikistan Tanzania, United Republic of Thailand Timor-Leste Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States Uruguay Uzbekistan Vanuatu Venezuela, Bolivarian Republic of Vietnam Virgin Islands, British Wallis and Futuna Western Sahara Yemen Zambia Zimbabwe In response, Collins announced several changes, including a new hospital board. And on 10 May, he said that Clinical Center Director John Gallin’s team would be replaced with a new leadership structure similar to that used by most hospitals: a chief executive officer, chief operating officer, and chief medical officer. Gallin’s team will stay on during the changes, Collins said.But Clinical Center staff say the Red Team’s report went too far. In the strongly worded letter dated 16 May from seven Center department heads and senior scientist Harvey Alter, they wrote that the claim that patient safety took a back seat to research is “quite simply, incorrect.” They suggested the Red Team would have come to different conclusions if they had met with more clinical research leaders and patients, examined positive reviews by outside accrediting organizations, and reviewed standard metrics for quality of care— such as data on patient falls and infections.Instead the Red Team “conflated deficiencies in certain clinical center operations” as “indicative of the quality” of individual patient care, stated the letter, first described by The Wall Street Journal. The resulting report and subsequent news coverage, they write, has “demonized [Clinical Center] leadership, demoralized high effective employees … and alarmed our patients.”Members of the Clinical Center’s patient advisory group have weighed in, too, noting in an open letter yesterday that they are not aware of any patient safety breaches. They make a plea to retain Gallin and his leadership team, who they argue have become “scapegoats” for broader problems, such as the center’s unsettled funding.A more measured 27 May letter, from a committee comprised of the clinical directors from NIH’s institutes, also expressed “concerns.” The authors pointed out that the center’s safety standards are actually higher than in most hospitals, because all patients are part of an approved research protocol and are closely monitored. At the same time, the committee agrees with some problems identified in the report, including the fact that funding for the Clinical Center’s operations comes from a tax on NIH institutes. The center needs its own budget stream and more dedicated money to make needed changes, the letter suggests.Another widely accepted conclusion in the Red Team report is that it is a problem that many staff working in the Clinical Center report to leaders at their institutes, and not the center’s leadership. Collins has already responded to this issue by giving these staff an additional reporting line to the Clinical Center director, NIH says. The Red Team’s chair, former Lockheed Martin CEO Norm Augustine, did not respond to an email request for comment. But team member Harlan Krumholz, a cardiologist at Yale University, defended the report’s conclusions, saying it was based on interviews with NIH experts, site visits, and reading “extensive materials.”“We saw clear opportunities to elevate systems so that they could more reliably ensure the safety” of patients, Krumholz told ScienceInsider. As for the report’s lack of data showing broader patient safety problems, he adds, “the issue that led to the Red Team should be evidence enough of a problem.”Today, NIH posted a “correction” to the Red Team report’s assertion that the Clinical Center has not collected common quality control measures. “In fact, the Clinical Center does collect metrics associated with patient safety,” but NIH is evaluating whether more are needed, the Red Team web page states. Although several signers of the 16 May letter did not respond to emails requesting comment, one NIH clinical research leader told ScienceInsider that “hundreds” of staff are upset by the Red Team’s report and Collins’s response, which they worry will “ruin” the Clinical Center. A group called the NIH Assembly of Scientists that represents intramural staff is also considering whether to write Collins, but was holding off until after the meeting with him today. Sign up for our daily newsletter Get more great content like this delivered right to you! Countrylast_img read more